Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation
- PMID: 28491142
- PMCID: PMC5405882
- DOI: 10.1177/1756283X17690480
Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation
Abstract
Fecal microbiota transplantation (FMT) is a very effective treatment for recurrent Clostridium difficile infection (CDI). Less is known about the application of FMT as a curative treatment of severe or complicated CDI. In this review, we present and discuss evidence supporting the curative use of FMT in severe or complicated CDI. We performed a literature search in PubMed and Embase for studies on the curative use of FMT in severe or complicated CDI. In addition, we describe a patient with severe CDI not responding to initial antibiotic treatment, who was successfully treated with curative FMT. We found 23 reports (12 case reports; 11 case series) about FMT as treatment for severe or complicated CDI. The patients described all had severe or complicated CDI, did not respond to conventional CDI antibiotic treatment and received FMT as last resort treatment. Patients were treated with (sequential) FMT, whether or not followed by additional antibiotic treatment for CDI. FMT, with or without additional antibiotic CDI treatment, appears to be a promising curative treatment option in patients with severe and complicated CDI, or only complicated CDI, who do not respond sufficiently to conventional antibiotic treatment. Treatment with FMT should be considered in these patients before proceeding to emergency bowel surgery.
Keywords: colectomy; fecal microbiota transplantation (FMT); gut microbiota; severe and complicated Clostridium difficile infection (CDI); treatment.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Similar articles
-
Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.Gut Microbes. 2017 May 4;8(3):289-302. doi: 10.1080/19490976.2016.1273998. Epub 2016 Dec 21. Gut Microbes. 2017. PMID: 28001467 Free PMC article.
-
Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital.J Glob Infect Dis. 2018 Apr-Jun;10(2):47-57. doi: 10.4103/jgid.jgid_145_17. J Glob Infect Dis. 2018. PMID: 29910564 Free PMC article.
-
Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.Aliment Pharmacol Ther. 2015 Aug;42(4):470-6. doi: 10.1111/apt.13290. Epub 2015 Jun 19. Aliment Pharmacol Ther. 2015. PMID: 26096320
-
Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.Chest. 2018 Jan;153(1):266-277. doi: 10.1016/j.chest.2017.09.002. Epub 2017 Sep 18. Chest. 2018. PMID: 28923757 Free PMC article. Review.
-
The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.Curr Treat Options Gastroenterol. 2017 Sep;15(3):349-362. doi: 10.1007/s11938-017-0143-1. Curr Treat Options Gastroenterol. 2017. PMID: 28748314 Review.
Cited by
-
Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.Aliment Pharmacol Ther. 2019 Nov;50(10):1094-1099. doi: 10.1111/apt.15526. Epub 2019 Oct 14. Aliment Pharmacol Ther. 2019. PMID: 31612528 Free PMC article.
-
Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection.Therap Adv Gastroenterol. 2019 Apr 10;12:1756284819843002. doi: 10.1177/1756284819843002. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31007720 Free PMC article.
-
rUTI Resolution After FMT for Clostridioides difficile Infection: A Case Report.Infect Dis Ther. 2021 Jun;10(2):1065-1071. doi: 10.1007/s40121-020-00365-8. Epub 2020 Nov 2. Infect Dis Ther. 2021. PMID: 33136261 Free PMC article.
-
Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.J Antimicrob Chemother. 2022 Dec 23;78(1):21-30. doi: 10.1093/jac/dkac404. J Antimicrob Chemother. 2022. PMID: 36441203 Free PMC article. Review.
-
Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation.Dig Dis Sci. 2020 Mar;65(3):741-756. doi: 10.1007/s10620-020-06102-y. Dig Dis Sci. 2020. PMID: 32008133 Review.
References
-
- Agrawal M., Aroniadis O., Brandt L., Kelly C., Freeman S., Surawicz C., et al. (2015) The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated clostridium difficile infection in 146 elderly individuals. J Clin Gastroenterol 50: 403–407. - PubMed
-
- Aroniadis O., Brandt L., Greenberg A., Borody T., Kelly C., Mellow M., et al. (2015) Long-term follow-up study of fecal microbiota transplantation for severe and/or complicated clostridium difficile infection: a multicenter experience. J Clin Gastroenterol 50: 398–402. - PubMed
-
- Asonuma K., Kuroki Y., Ino S., Hanamura S., Takano Y., Yamamura E., et al. (2016) Severe refractory clostridium difficile infection with good response to fecal microbiota transplantation: a case report. Nihon Shokakibyo Gakkai Zasshi 113: 55–62. - PubMed
-
- Berman L., Carling T., Fitzgerald T., Bell R., Duffy A., Longo W., et al. (2008) Defining surgical therapy for pseudomembranous colitis with toxic megacolon. J Clin Gastroenterol 42: 476–480. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical